Tygrus
Troy, US · Founded 2012 · Delaware LLC
Find your way into Tygrus
Sign up to see every warm intro you have to Tygrus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tygrus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tygrus is a life science research, development, and licensing company that develops safer chemical alternatives based on its patented Tydronium acid, used to replace hazardous disinfectants, toxic preservatives, and other harmful chemicals. Through wholly owned subsidiaries, it licenses this technology across agriculture (Aqueus/Growthful), respiratory therapeutics (Miracus/Tydracin), and personal care (Wonderus), and is headquartered in Troy, Michigan.
Founders & leadership

Board
Reported raises · per SEC filings
Form D private placements$3.7M disclosed across 6 of 7 rounds · 2015–2020
▶$1.2MraisedFeb 2021 · 3 investors · ManufacturingRule 506(b)
- John CoppolinoExecutive Officer
- Timothy L. HoelDirector
- Lawrence CarlsonExecutive Officer, Director
- Arthur B. McWoodExecutive Officer, Director
- Jason YoffyExecutive Officer
- Larry AdloffDirector
- Daniel J. JenuwineExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.2M
- Minimum investment
- $100K
- Proceeds to insiders
- $200K
- First sale
- Dec 2020
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$941.8KraisedNov 2019 · 19 investors · ManufacturingRule 506(b)
- John CoppolinoExecutive Officer
- Lawrence CarlsonExecutive Officer, Director
- Jason YoffyExecutive Officer
- Timothy L. HoelDirector
- Daniel J. JenuwineExecutive Officer, Director
- Arthur B. McWoodExecutive Officer, Director
- Larry AdloffDirector
- Offering amount
- $2M
- Amount sold
- $941.8K
- Minimum investment
- $20K
- Proceeds to insiders
- $250K
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$500KraisedNov 2019 · 5 investors · ManufacturingRule 506(b)
- Daniel J. JenuwineExecutive Officer, Director
- Arthur B. McWoodExecutive Officer, Director
- John CoppolinoExecutive Officer
- Jason YoffyExecutive Officer
- Timothy L. HoelDirector
- Larry AdloffDirector
- Lawrence CarlsonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $500K
- Minimum investment
- $50K
- Proceeds to insiders
- $200K
- First sale
- Oct 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1MraisedApr 2018 · 1 investors · ManufacturingRule 506(b)
- Lawrence CarlsonExecutive Officer, Director
- Arthur B. McWoodExecutive Officer, Director
- Daniel J. JenuwineExecutive Officer, Director
- Timothy L. HoelDirector
- Jason YoffyExecutive Officer
- Larry AdloffDirector
- John CoppolinoExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- Proceeds to insiders
- $250K
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$50KraisedJul 2016 · ManufacturingRule 506(b)
- Jason YoffyExecutive Officer
- Larry AdloffDirector
- Timothy L. HoelDirector
- Arthur B. McWoodExecutive Officer, Director
- John CoppolinoExecutive Officer
- Lawrence CarlsonExecutive Officer, Director
- Daniel J. JenuwineExecutive Officer, Director
- Jeanne ThomaExecutive Officer
- Offering amount
- $2M
- Amount sold
- $50K
- Minimum investment
- $50K
- Proceeds to insiders
- $365K
- First sale
- Jul 2016
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
▶$25KraisedAug 2015 · 1 investors · ManufacturingRule 506(b)
- Lawrence CarlsonExecutive Officer, Director
- John CoppolinoExecutive Officer
- Timothy HoelDirector
- Arthur B. McWoodExecutive Officer, Director
- Daniel J. JenuwineExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $25K
- Minimum investment
- $25K
- Proceeds to insiders
- $150K
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
▶$1.5MofferedJan 2015 · ManufacturingRule 506(b)
- Timothy L. HoelDirector
- Lawrence CarlsonExecutive Officer, Director
- John CoppolinoExecutive Officer, Director
- Daniel J. JenuwineExecutive Officer, Director
- Stephen R. WurzburgerDirector
- Arthur B. McWoodExecutive Officer, Director
- Offering amount
- $1.5M
- Minimum investment
- $100K
- Proceeds to insiders
- $300K
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Tygrus do?
- Tygrus is a life science research, development, and licensing company that develops safer chemical alternatives based on its patented Tydronium acid, used to replace hazardous disinfectants, toxic preservatives, and other harmful chemicals. Through wholly owned subsidiaries, it licenses this technology across agriculture (Aqueus/Growthful), respiratory therapeutics (Miracus/Tydracin), and personal care (Wonderus), and is headquartered in Troy, Michigan.
- How much funding has Tygrus raised?
- Tygrus has disclosed $3.7M raised across 6 of its 7 known rounds.
- Where is Tygrus headquartered?
- Tygrus is headquartered in Troy, US.